56 related articles for article (PubMed ID: 16271833)
1. Increase in phosphotidylinositide-3 kinase activity by nitrotyrosylation of lysates of platelets from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Biochim Biophys Acta; 2006 Jan; 1760(1):32-7. PubMed ID: 16271833
[TBL] [Abstract][Full Text] [Related]
2. Alteration in protein kinase B (AKT) activity in platelets from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Thromb Res; 2008; 122(4):501-6. PubMed ID: 18355897
[TBL] [Abstract][Full Text] [Related]
3. A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Biochim Biophys Acta; 2007 Aug; 1770(8):1181-6. PubMed ID: 17524560
[TBL] [Abstract][Full Text] [Related]
4. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis.
Chiang TM; Takayama H; Postlethwaite AE
Thromb Res; 2006; 117(3):299-306. PubMed ID: 16378833
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide synthase in collagen-platelet interaction: involvement of platelet nonintegrin collagen receptor nitrotyrosylation.
Chiang TM; Cole F; Woo-Rasberry V; Kang ES
Thromb Res; 2001 May; 102(4):343-52. PubMed ID: 11369427
[TBL] [Abstract][Full Text] [Related]
6. Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
Massabki PS; Silva NP; Lourenço DM; Andrade LE
J Rheumatol; 2003 Dec; 30(12):2606-12. PubMed ID: 14719201
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived-growth-factor-induced signalling in human platelets: phosphoinositide-3-kinase-dependent inhibition of platelet activation.
Selheim F; Fukami MH; Holmsen H; Vassbotn FS
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):469-75. PubMed ID: 10947961
[TBL] [Abstract][Full Text] [Related]
8. Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk.
Saci A; Rendu F; Bachelot-Loza C
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):669-76. PubMed ID: 11042121
[TBL] [Abstract][Full Text] [Related]
9. A collagen-related peptide regulates phospholipase Cgamma2 via phosphatidylinositol 3-kinase in human platelets.
Pasquet JM; Bobe R; Gross B; Gratacap MP; Tomlinson MG; Payrastre B; Watson SP
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):171-7. PubMed ID: 10432314
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-stimulated phosphatidylinositol 3-kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation independent.
Sayed MR; Sheid MP; Stevens CM; Duronio V
J Cell Physiol; 2000 Jun; 183(3):314-20. PubMed ID: 10797305
[TBL] [Abstract][Full Text] [Related]
11. Dextran sulphate induces fibrinogen receptor activation through a novel Syk-independent PI-3 kinase-mediated tyrosine kinase pathway in platelets.
Getz TM; Manne BK; Buitrago L; Mao Y; Kunapuli SP
Thromb Haemost; 2013 Jun; 109(6):1131-40. PubMed ID: 23571309
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester mediated activation of inducible nitric oxide synthase results in platelet profilin nitration.
Kasina S; Wasia R; Fasim A; Radhika KV; Singh SS
Nitric Oxide; 2006 Feb; 14(1):65-71. PubMed ID: 16288977
[TBL] [Abstract][Full Text] [Related]
14. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
[TBL] [Abstract][Full Text] [Related]
17. Variations in platelet protein associated with arterial thrombosis.
Arias-Salgado EG; Larrucea S; Butta N; Fernández D; García-Muñoz S; Parrilla R; Ayuso MS
Thromb Res; 2008; 122(5):640-7. PubMed ID: 18417195
[TBL] [Abstract][Full Text] [Related]
18. The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.
Pauling JD; O'Donnell VB; Mchugh NJ
Platelets; 2013; 24(7):503-15. PubMed ID: 22966961
[TBL] [Abstract][Full Text] [Related]
19. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins.
Marcus K; Immler D; Sternberger J; Meyer HE
Electrophoresis; 2000 Jul; 21(13):2622-36. PubMed ID: 10949139
[TBL] [Abstract][Full Text] [Related]
20. Platelet phosphatidylinositol kinase activity is not altered in Alzheimer disease.
Bothmer J; Markerink M; Coppens R; Jolles J
Mol Chem Neuropathol; 1993 Aug; 19(3):249-57. PubMed ID: 8397585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
